Cite

HARVARD Citation

    Bellanger, C. et al. (n.d.). P474 Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD). Journal of Crohn's and colitis. pp. S343-S344. [Online]. 
  
Back to record